Arg-Gly-Asp-Ser is an Integrin-binding sequence that inhibits Integrin receptor function. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, MMP-9, and iNOS.